“stem-cells” Archives

in
Entry Author Date Location
iPierian Nabs $30M To Keep Alzheimer’s, Autoimmune Drugs Moving 09/04/13 San Francisco
San Diego Life Sciences Roundup: Vical, Fate, Arcturus, and More 08/15/13 San Diego
Fate Therapeutics Joins Biotech IPO Conga Line, Reaching for $69M 08/14/13 San Diego
San Diego Life Sciences Roundup: Regulus, Ocera, Lithera, and More 07/18/13 San Diego
SMC Bio Looks to Heal Bones With Carbohydrates, Not Stem Cells 07/18/13 San Francisco
Cellular Dynamics, Coriell To Create California Stem Cell Bank 06/17/13 San Francisco
Verastem Switches CEOs as Westphal Steps Into Chairman Role 06/06/13 Boston
Histogen Forms Joint Venture to Advance Regenerative Orthopedics 03/11/13 San Diego
California Stem Cell Agency Shifts Focus to Clinical Treatments 01/31/13 San Francisco
The Fiscal Cliff Is Forcing a Biomedical Day of Reckoning 12/31/12 National
Geron Pinning Hopes On Single Drug Platform 12/19/12 San Francisco
Moderna, $40M in Tow, Hopes to Reinvent Biotech with “Make Your Own Drug” 12/06/12 Boston
ViaCyte CEO Says $10M Grant Will Move Stem Cell Therapy to Trial 10/30/12 San Diego
Translating Nobel Science Into Novel Drugs 10/12/12 San Francisco
San Diego Life Sciences Roundup: Optimer, CareFusion, Senomyx & More 10/11/12 San Diego
San Diego Life Sciences Roundup: Santarus, Shire, Illumina, & More 09/06/12 San Diego
Brace Yourself: Biotech IPOs Are Beating Tech’s Big Names 08/13/12 National
SD at Center of Shire’s Plan for Regenerative Medicine Business 06/14/12 San Diego
Xconomist of the Week: Evan Snyder—Stem Cell Reality Check 05/25/12 San Diego
iPierian Zeroes In on Antibodies for Alzheimer’s, Neurodegeneration 05/21/12 San Francisco
Progress for Pervasis and InVivo: A Boost for Regenerative Efforts? 04/19/12 Boston
Adimab, ImmunoGen, OvaScience, & More Boston Life Sciences News 04/06/12 Boston
OvaScience Adds $37M for Fertility Treatments 04/04/12 Boston
Celladon Raises $43M, Wins Fast-Track Status for Heart Treatment 02/15/12 San Diego
Fate Therapeutics Names Biotech Vet Bill Rastetter as Chairman, Interim CEO 12/14/11 San Diego
Harvard Bioscience Tool Used in First Transplants of Synthetic Tracheae 12/01/11 Boston
AlloCure Stem Cell Trial Provides Glimpse of Promising Treatment for Kidney Damage 11/18/11 Boston
Geron Dumps Stem Cell R&D Programs, Axes 38% of Workforce 11/14/11 San Francisco
Tolerx Shutters, Courtagen Gets $8M, OvaScience Emerges, & More Boston-Area Life Sciences News 10/14/11 Boston
Amgen Mulls R&D Cuts, Thong Le Named WBBA Chairman, NanoString’s Version 2.0, & More Seattle-Area Life Sciences News 10/13/11 Seattle
Page 3 of 8 « previous page · next page »